High and selective expression of yeast cytosine deaminase under a carcinoembryonic antigen promoter-enhancer

Cancer Research

Volumn 62, Issue 8, 2002, Pages 2337-2342

  Nyati, Mukesh K ^a   Sreekumar, Arun ^a   Li, Shengping ^a   Zhang, Ming ^a   Rynkiewicz, Susan D ^a   Chinnaiyan, Arul M ^a   Rehemtulla, Alnawaz ^a   Lawrence, Theodore S ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; CYTOSINE DEAMINASE; FLUCYTOSINE; FLUOROURACIL; VIRUS VECTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; CYTOMEGALOVIRUS; ENZYME ACTIVITY; GENE THERAPY; GENE TRANSFER; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; ROUS SARCOMA ONCOVIRUS; TRANSGENE; TUMOR GROWTH; XENOGRAFT;

ADENOVIRIDAE; ANIMALS; AVIAN SARCOMA VIRUSES; CARCINOEMBRYONIC ANTIGEN; CYTOSINE DEAMINASE; FEMALE; GENE THERAPY; HT29 CELLS; HUMANS; LIVER NEOPLASMS, EXPERIMENTAL; MICE; MICE, NUDE; NUCLEOSIDE DEAMINASES; PROMOTER REGIONS (GENETICS); SACCHAROMYCES CEREVISIAE; TUMOR CELLS, CULTURED; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 0037089556     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Treatment of liver cancer: Current status and future prospectives
2. Implantable enzyme capsules for cancer chemotherapy from bakers' yeast cytosine deaminase immobilized on epoxy-acrylic resin and urethane prepolymer
3. Generation of 5-fluorouracil from 5-fluorocytosine by monoclonal antibody-cytosine deaminase conjugates
4. A first step in the development of gene therapy for colorectal carcinoma: Cloning, sequencing, and expression of Escherichia coli cytosine deaminase
5. In vivo adenovirus-mediated gene transfer of the Escherichia coli cytosine deaminase gene to human colon carcinoma-derived tumors induces chemosensitivity to 5-fluorocytosine
6. Enzyme/prodrug gene therapy: Comparison of cytosine deaminase/5-fluorocytosine versus thymidine kinase/ganciclovir enzyme/prodrug systems in a human colorectal carcinoma cell line
7. In vivo replication-deficient adenovirus vector-mediated transduction of the cytosine deaminase gene sensitizes glioma cells to 5- luorocytosine
8. Phase I study of direct administration of a replication deficient adenovirus vector containing the E. coli cytosine deaminase gene to metastatic colon carcinoma of the liver in association with the oral administration of the prodrug 5-fliuorocytosine
9. Cloning, overexpression, and purification of cytosine deaminase from Saccharomyces cerevisiae
10. Effective and safe gene therapy for colorectal carcinoma using the cytosine deaminase gene directed by the carcinoembryonic antigen promoter
11. Enzyme/prodrug therapy for head and neck cancer using a catalytically superior cytosine deaminase
12. Superiority of yeast over bacterial cytosine deaminase for enzyme/prodrug gene therapy in colon cancer xenografts
13. Noninvasive quantitation of cytosine deaminase transgene expression in human tumor xenografts with in vivo magnetic resonance spectroscopy
14. Yeast cytosine deaminase improves radiosensitization and bystander effect by 5-fluorocytosine of human colorectal cancer xenografts
15. Virally directed cytosine deaminase/5-fluorocytosine gene therapy enhances radiation response in human cancer xenografts
16. FGF2-targeted adenoviral vectors for systemic and local disease
17. Transcriptional control: An essential component of cancer gene therapy strategies?
18. Spatiotemporal expression of murine carcinoembryonic antigen (CEA) gene family members during mouse embryogenesis
19. Directed enzyme prodrug gene therapy for pancreatic cancer in vivo
20. Targeted gene transfer for adenocarcinoma using a combination of tumor-specific antibody and tissue-specific promoter
21. Tumor-specific gene expression in carcinoembryonic antigen: Producing gastric cancer cells using adenovirus vectors
22. Carcinoembryonic antigen-specific suicide gene therapy of cytosine deaminase/5-fluorocytosine enhanced by the cre/loxp system in the orthotopic gastric carcinoma model
23. In vivo gene therapy for α-fetoprotein-producing hepatocellular carcinoma by adenovirus-mediated transfer of cytosine deaminase gene
24. Variability of adenovirus receptor density influences gene transfer efficiency and therapeutic response in head and neck cancer
25. CAR-dependent and CAR-independent pathways of adenovirus vector-mediated gene transfer and expression in human fibroblasts
26. Adenovirus-mediated gene therapy of gastric carcinoma using cancer-specific gene expression in vivo
27. Transcriptional regulatory sequences of carcinoembryonic antigen: Identification and use with cytosine deaminase for tumor-specific gene therapy
28. Application of the Cre recombinase/loxP system further enhances antitumor effects in cell type-specific gene therapy against carcinoembryonic antigen-producing cancer
29. The carcinoembryonic antigen (CEA) family: Structures, suggested functions, and expression in normal and malignant tissues
30. Tissue-specific, tumor-selective, replication-competent adenovirus vector for cancer gene therapy